1 / 11

Hepatic Safety of Latest Antiretrovirals in HIV/HCV Coinfection

Understand liver toxicity risk with recent antiretrovirals in HIV/HCV coinfection. Explore influences on liver enzyme elevation and fibrosis impact on toxicity predictors.

keo
Download Presentation

Hepatic Safety of Latest Antiretrovirals in HIV/HCV Coinfection

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Low Risk of Liver Toxicity of Most Recently Approved Antiretroviral Agents, and Influence of Hepatitis C Coinfection

  2. Baseline characteristics of the study population

  3. LEE according to antiretroviral drug used as third agent

  4. Any grade of LEE for single antiretroviral drugs

  5. Influence of liver fibrosis on LEE

  6. Predictors of liver toxicity

More Related